Bioactive Compound Applications in Respiratory Health

Bioactive compounds derived from plants and other natural sources are increasingly recognised for their potential to prevent or ameliorate respiratory diseases through anti-inflammatory, antioxidant, antiviral and mucolytic mechanisms. Classes of compounds under active investigation include polyphenols (for example flavonoids and stilbenes), terpenoids (including monoterpenes and sesquiterpenes), alkaloids and sulphated polysaccharides. These agents target key pathways in asthma, chronic obstructive pulmonary disease (COPD), acute bronchitis and viral pneumonia by modulating cytokine release, scavenging reactive oxygen species, inhibiting viral entry or replication, and enhancing mucociliary clearance. Recent advances in formulation science have enabled the development of inhalable nanoparticles, lipid-based carriers and biodegradable microparticles to improve pulmonary delivery and bioavailability. Such approaches are aligned with a growing interest in precision pulmonology, where targeted delivery of bioactives can reduce systemic exposure and improve safety. Taken together, this field offers globally significant opportunities for non-steroidal, adjunctive or prophylactic interventions in a broad spectrum of respiratory conditions, with implications for pandemic preparedness, chronic disease management and health equity in resource-limited settings.

Research from Nature Portfolio

Recent studies have harnessed novel delivery platforms to enhance the therapeutic impact of natural anti-inflammatory and antioxidant agents in preclinical models of lung injury. In one investigation, curcumin was encapsulated within endogenous exosomes and administered via inhalation in murine bacterial pneumonia; this approach improved macrophage phagocytosis, reduced neutrophil infiltration and lowered levels of pro-inflammatory cytokines such as tumour necrosis factor-α and interleukin-6. Another study employed alginate-based microparticles loaded with resveratrol to treat influenza-induced lung oxidative stress; treated animals exhibited restored pulmonary compliance, decreased lipid peroxidation and preserved alveolar architecture. A complementary report described quercetin nanoparticles engineered for sustained release in the bronchial tree of an asthma model; these particles attenuated airway hyperresponsiveness, suppressed eosinophil infiltration and downregulated the expression of key chemokines involved in allergic inflammation.

Bioactive Compound Applications in Respiratory Health publication trend

The graph below shows the total number of articles in bioactive compound applications in respiratory health across all publications each year (not limited to Nature Index journals).

Technical terms

Polyphenols: Natural compounds containing multiple phenolic moieties, conferring antioxidant and anti-inflammatory properties.

Terpenoids: A diverse class of isoprene-derived natural products often exhibiting bronchodilatory and anti-inflammatory effects.

Exosomes: Nanometre-sized extracellular vesicles capable of delivering lipids, proteins and nucleic acids between cells.

Alginate microparticles: Biodegradable biopolymer carriers that enable sustained release of bioactives in the lung environment.

Airway hyperresponsiveness: Exaggerated constrictive response of the bronchial tree to stimuli, characteristic of asthma.

Mucolytic: Agent that reduces the viscosity of bronchial mucus, facilitating clearance from the airways.

References

1. Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review. European Journal of Clinical Pharmacology (2021).